Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026)
Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7,249.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -191.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | 499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 499.00 |
| Dec 31, 2025 | 433.00 |
| Sep 30, 2025 | 770.00 |
| Jun 30, 2025 | 331.00 |
| Mar 31, 2025 | 96.00 |
| Dec 31, 2024 | 9,270.00 |
| Sep 30, 2024 | 4,239.00 |
| Jun 30, 2024 | 2,129.00 |
| Mar 31, 2024 | 2,186.00 |
| Dec 31, 2023 | 1,985.00 |
| Sep 30, 2023 | 430.00 |
| Jun 30, 2023 | 1,549.00 |
| Mar 31, 2023 | 1,330.00 |
| Dec 31, 2022 | 458.00 |
| Sep 30, 2022 | 1,227.00 |
| Jun 30, 2022 | 901.00 |
| Mar 31, 2022 | 397.00 |
| Dec 31, 2021 | -9,121.00 |
| Sep 30, 2021 | -3,983.00 |
| Jun 30, 2021 | -2,025.00 |